July 30, 2014 1:48 PM ET

Capital Markets

Company Overview of DRI Capital Inc.

Company Overview

DRI Capital Inc. is a private equity arm of Persis Holdings Ltd. specializing in investments in late venture and buyouts. It seeks to invest in products in healthcare and life sciences sector that treat chronic, and or rare diseases which improve the health and quality of a patient’s life. The firm seeks to acquire royalties globally from pharmaceutical and biotechnology companies, research institutes, universities, and inventors. Additionally, it considers investments in royalty entitlements on medical devices, diagnostic products, life sciences tools and technologies, drug, and pharmaceutical products. The firm invests worldwide with a focus on Japan, Europe, and the United States. It inve...

22 Saint Clair Avenue East

Suite 200

Toronto, ON M4T 2S5

Canada

Founded in 1992

Phone:

416-863-1865

Fax:

416-863-5161

Key Executives for DRI Capital Inc.

Chief Operating Officer
Managing Director
Principal
Managing Director
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DRI Capital Inc., please visit www.dricapital.com/. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.